29
Participants
Start Date
April 21, 2021
Primary Completion Date
April 28, 2023
Study Completion Date
April 28, 2023
conestat alfa or placebo
"Conestat alfa will be dosed by body weight at 50 U/kg (maximum 4200 U) or 100 U/kg (maximum 8400 U).~Placebo will consist of normal saline (NaCl 0.9%). The interventions will be given to the patients by IV-line."
University Hospital Geneva, Geneva
Inselspital Bern, Bern
University Hospital Basel, Basel
Fondazione Istituto Cardiocentro Ticino, Lugano
Lead Sponsor
Pharming Technologies B.V.
INDUSTRY